Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolf Hoffmann

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 25, 2007
Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in womenUlrike Blume-Peytavi, Christian Kunte, Andreas Krisp, et al.
Experimental Dermatology|November 6, 2007
Interleukin-6 cytokine family member oncostatin M is a hair-follicle-expressed factor with hair growth inhibitory propertiesMei Yu, Sabine Kissling, Pia Freyschmidt-Paul, et al.
European Journal of Dermatology : EJD|July 4, 2002
Diphencyprone immunotherapy alters anti-hair follicle antibody status in patients with alopecia areataDesmond J Tobin, Sarah H Gardner, Nigel J Lindsey, et al.
The Journal of Investigative Dermatology|April 28, 2005
Transfer of CD8(+) cells induces localized hair loss whereas CD4(+)/CD25(-) cells promote systemic alopecia areata and CD4(+)/CD25(+) cells blockade disease onset in the C3H/HeJ mouse modelKevin J McElwee, Pia Freyschmidt-Paul, Rolf Hoffmann, et al.
The Journal of Investigative Dermatology|December 18, 2002
Resistance to alopecia areata in C3H/HeJ mice is associated with increased expression of regulatory cytokines and a failure to recruit CD4+ and CD8+ cellsKevin J McElwee, Rolf Hoffmann, Pia Freyschmidt-Paul, et al.
Skin Pharmacology and Physiology|September 12, 2019
Autologous Cell Therapy for Aged Human Skin: A Randomized, Placebo-Controlled, Phase-I StudySusanne Grether-Beck, Alessandra Marini, Thomas Jaenicke, et al.
The Journal of Investigative Dermatology|October 31, 2002
Interleukin-10-deficient mice are less susceptible to the induction of alopecia areataPia Freyschmidt-Paul, Kevin J McElwee, Rudolf Happle, et al.
European Journal of Dermatology : EJD|September 4, 2009
European Consensus on the evaluation of women presenting with excessive hair growthUlrike Blume-Peytavi, Stephen Atkin, Jerry Shapiro, et al.
The Journal of Investigative Dermatology. Symposium Proceedings|August 5, 2003
Fas-deficient C3.MRL-Tnfrsf6(lpr) mice and Fas ligand-deficient C3H/HeJ-Tnfsf6(gld) mice are relatively resistant to the induction of alopecia areata by grafting of alopecia areata-affected skin from C3H/HeJ micePia Freyschmidt-Paul, Kevin J McElwee, Vladimir Botchkarev, et al.
The Journal of Investigative Dermatology|November 22, 2005
Reduced expression of interleukin-2 decreases the frequency of alopecia areata onset in C3H/HeJ micePia Freyschmidt-Paul, Kevin J McElwee, Rolf Hoffmann, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 25, 2007
Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in womenUlrike Blume-Peytavi, Christian Kunte, Andreas Krisp, et al.
Experimental Dermatology|November 6, 2007
Interleukin-6 cytokine family member oncostatin M is a hair-follicle-expressed factor with hair growth inhibitory propertiesMei Yu, Sabine Kissling, Pia Freyschmidt-Paul, et al.
European Journal of Dermatology : EJD|July 4, 2002
Diphencyprone immunotherapy alters anti-hair follicle antibody status in patients with alopecia areataDesmond J Tobin, Sarah H Gardner, Nigel J Lindsey, et al.
The Journal of Investigative Dermatology|April 28, 2005
Transfer of CD8(+) cells induces localized hair loss whereas CD4(+)/CD25(-) cells promote systemic alopecia areata and CD4(+)/CD25(+) cells blockade disease onset in the C3H/HeJ mouse modelKevin J McElwee, Pia Freyschmidt-Paul, Rolf Hoffmann, et al.
The Journal of Investigative Dermatology|December 18, 2002
Resistance to alopecia areata in C3H/HeJ mice is associated with increased expression of regulatory cytokines and a failure to recruit CD4+ and CD8+ cellsKevin J McElwee, Rolf Hoffmann, Pia Freyschmidt-Paul, et al.
Skin Pharmacology and Physiology|September 12, 2019
Autologous Cell Therapy for Aged Human Skin: A Randomized, Placebo-Controlled, Phase-I StudySusanne Grether-Beck, Alessandra Marini, Thomas Jaenicke, et al.
The Journal of Investigative Dermatology|October 31, 2002
Interleukin-10-deficient mice are less susceptible to the induction of alopecia areataPia Freyschmidt-Paul, Kevin J McElwee, Rudolf Happle, et al.
European Journal of Dermatology : EJD|September 4, 2009
European Consensus on the evaluation of women presenting with excessive hair growthUlrike Blume-Peytavi, Stephen Atkin, Jerry Shapiro, et al.
The Journal of Investigative Dermatology. Symposium Proceedings|August 5, 2003
Fas-deficient C3.MRL-Tnfrsf6(lpr) mice and Fas ligand-deficient C3H/HeJ-Tnfsf6(gld) mice are relatively resistant to the induction of alopecia areata by grafting of alopecia areata-affected skin from C3H/HeJ micePia Freyschmidt-Paul, Kevin J McElwee, Vladimir Botchkarev, et al.
The Journal of Investigative Dermatology|November 22, 2005
Reduced expression of interleukin-2 decreases the frequency of alopecia areata onset in C3H/HeJ micePia Freyschmidt-Paul, Kevin J McElwee, Rolf Hoffmann, et al.
Pageof 4